Microbes are found in every biome of life and are even associated with hosts. Microbes and their hosts form complex ‘super-organisms’ in which symbiotic relationships maintain many key aspects of life. Changes to these microbial communities, through infection, disease or lifestyle, can disrupt vital functions and even promote disease.
What do we offer?
We perform multi-omics mapping of full microbial communities to determine species composition and examine the causal role of a specific microbiome in selected disease states. Our workflows are used for human, animal, plant and environmental systems, and are currently compatible with 16SrRNA data from Illumina PE & SE, and Pacbio SE.
We implement state-of-the-art statistics to calculate causal statistics by the comparative weighting of genetic, microbial and external factors to predict disease development, progression and resistance. By using a combination of biostatistical frameworks and artificial intelligence tools we examine modifiable risk factors to establish the most viable drug targets and biomarkers in microbiome-associated illnesses as well as develop bioremediation approaches.
Our workflow generates reports on quality, taxonomy, diversity, as well as differential abundance analyses. This is all neatly packed into an interactive web-based report providing all the necessary details to you in a user-friendly interface.
Check out our new microbiome analysis platform proBiome for more information.